These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23314317)

  • 1. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease.
    Yee-Moon Wang A; Lu Y; Cheung S; Hiu-Shuen Chan I; Wai-Kei Lam C
    Nephrol Dial Transplant; 2013 Sep; 28(9):2319-28. PubMed ID: 23314317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of left atrial enlargement diagnosed by electrocardiography as compared to cardiac magnetic resonance in hypertensive patients.
    Bureekam S; Boonyasirinant T
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S132-8. PubMed ID: 24772590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients.
    Armario P; Oliveras A; Hernández-Del-Rey R; Suárez C; Martell N; Ruilope LM; De La Sierra A;
    Blood Press; 2013 Feb; 22(1):39-44. PubMed ID: 23305454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to left atrial enlargement in adults with normal left ventricular systolic function.
    Katayama T; Fujiwara N; Tsuruya Y
    J Cardiol; 2010 Mar; 55(2):196-204. PubMed ID: 20206072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors.
    Sciacqua A; Perticone M; Tripepi G; Miceli S; Tassone EJ; Grillo N; Carullo G; Sesti G; Perticone F
    Int J Cardiol; 2014 Jul; 175(1):90-5. PubMed ID: 24836687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.
    Iwasaki M; Joki N; Tanaka Y; Ikeda N; Hayashi T; Kubo S; Asakawa T; Takahashi Y; Hirahata K; Imamura Y; Hase H
    Nephrology (Carlton); 2013 Jul; 18(7):497-504. PubMed ID: 23574011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of left atrial enlargement and its risk factors in general Chinese population.
    Ou Q; Chen Y; Yu S; Guo X; Zhao H; Sun Y
    BMC Cardiovasc Disord; 2016 Mar; 16():53. PubMed ID: 26944401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of chronic kidney disease with impaired left atrial reservoir function: A community-based cohort study.
    Nakanishi K; Jin Z; Russo C; Homma S; Elkind MS; Rundek T; Tugcu A; Sacco RL; Di Tullio MR
    Eur J Prev Cardiol; 2017 Mar; 24(4):392-398. PubMed ID: 27856809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower plasma sodium is associated with a microinflammatory state among patients with advanced chronic kidney disease.
    Ortega O; Cobo G; Rodríguez I; Camacho R; Gallar P; Mon C; Herrero JC; Ortiz M; Oliet A; Di Gioia C; Vigil A
    Nephron Clin Pract; 2014; 128(3-4):312-8. PubMed ID: 25472577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study.
    Stritzke J; Markus MR; Duderstadt S; Lieb W; Luchner A; Döring A; Keil U; Hense HW; Schunkert H;
    J Am Coll Cardiol; 2009 Nov; 54(21):1982-9. PubMed ID: 19909880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise blood pressure and echocardiographic abnormalities in genetically comparable populations.
    Naimark BJ; Axelsson J; Sigurdsson SB; Stephens NL
    Can J Cardiol; 1992 Jun; 8(5):471-7. PubMed ID: 1535539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
    Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for recurrent heart failure in patients post-myocardial infarction with electrocardiographic and echocardiographic left atrial abnormality.
    Ariyarajah V; Malinski M; Zieroth S; Harizi R; Morris A; Spodick DH
    Am J Cardiol; 2008 May; 101(10):1373-8. PubMed ID: 18471444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.
    Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS
    J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients.
    Okumura K; Io H; Matsumoto M; Seto T; Takagi M; Masuda A; Furukawa M; Nagahama L; Omote K; Hisada A; Hamada C; Horikoshi S; Tomino Y
    Clin Nephrol; 2013 Jan; 79(1):7-14. PubMed ID: 23036229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.